Could a single injection fix your aching back? new trial tests disc repair cells
NCT ID NCT03955315
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial tested an experimental treatment called IDCT (injectable disc cell therapy) in 38 people with chronic low back pain due to degenerative disc disease. Participants received either a low or high dose of the cell therapy or a sham procedure. The goal was to check safety and see if the treatment reduces pain and disability. Results are still being analyzed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Injectable disc cell therapy (discogenic cells mixed with sodium hyaluronate)
What this could lead to
If successful, this could lead to a non-surgical treatment that repairs damaged spinal discs and reduces chronic low back pain.
What could go wrong
This is an early phase I/II trial with only 38 participants, so results are preliminary. The treatment may not work better than a sham procedure, and there could be unknown side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEGENERATIVE DISC DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chiba University Hospital
Chuo-ku, Chiba, 260-8670, Japan
-
Mie University Hospital
Tsu, Mie-ken, 514-8507, Japan
-
Nagoya university hospital
Shōwaku, Nagoya, 466-8550, Japan
-
Osaka University Hospital
Suita, Osaka, 565-0871, Japan
-
Tokai University Hospital
Isehara, Kanagawa, 259-1193, Japan
-
University of Yamanashi Hospital
Chūō, Yamanashi, 409-3898, Japan